NCT00392691 arm group 7aa3e6d4b5ea955d40d2ce652890fd98 [clinicaltrials_resource:NCT00392691/arm-group/7aa3e6d4b5ea955d40d2ce652890fd98]
autologous hematopoietic stem cell harvesting and transplantation [clinicaltrials_resource:3955f64dd71d7361b61916261847c882]rituximab [clinicaltrials_resource:6a165192b7778a54e560d03e220bfad3]vinorelbine tartrate / G-CSF [clinicaltrials_resource:981a5777bae7ddc93afdc9ff95bfefd9]melphalan [clinicaltrials_resource:e6320a5ef406c289f7f4fec91dce2def]ibritumomab tiuxetan [clinicaltrials_resource:f3c5a84203696da2d81ac968d3e28b31]Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment [clinicaltrials:NCT00392691]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00392691 arm group 7aa3e6d4b5ea955d40d2ce652890fd98 [clinicaltrials_resource:NCT00392691/arm-group/7aa3e6d4b5ea955d40d2ce652890fd98]
Bio2RDF identifier
NCT00392691/arm-group/7aa3e6d4b5ea955d40d2ce652890fd98
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... a3e6d4b5ea955d40d2ce652890fd98
identifier
clinicaltrials_resource:NCT00392691/arm-group/7aa3e6d4b5ea955d40d2ce652890fd98
title
NCT00392691 arm group 7aa3e6d4b5ea955d40d2ce652890fd98
@en
type
label
NCT00392691 arm group 7aa3e6d4 ...... 3e6d4b5ea955d40d2ce652890fd98]
@en